Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans

Laboratory investigation

Restricted access

Object

Glioblastoma is the most aggressive malignant brain tumor, and overall patient survival has not been prolonged even by conventional therapies. Previously, the authors found that chemically synthesized glycans could be anticancer agents against growth of a series of cancer cells. In this study, the authors examined the effects of glycans on the growth of glioblastoma cells both in vitro and in vivo.

Methods

The authors investigated not only the occurrence of changes in the cell signaling molecules and expression levels of various proteins related to cell death, but also a mouse model involving the injection of glioblastoma cells following the administration of synthetic glycans.

Results

Synthetic glycans inhibited the growth of glioblastoma cells, induced the apoptosis of the cells with cleaved poly (adenosine diphosphate-ribose) polymerase (PARP) expression and DNA fragmentation, and also caused autophagy, as shown by the detection of autophagosome proteins and monodansylcadaverine staining. Furthermore, tumor growth in the in vivo mouse model was significantly inhibited. A dramatic induction of programmed cell death was found in glioblastoma cells after treatment with synthetic glycans.

Conclusions

These results suggest that synthetic glycans could be a promising novel anticancer agent for performing chemotherapy against glioblastoma.

Abbreviations used in this paper:Akt = protein kinase B; AMPA = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CPI = cell proliferation inhibition; HP-β-CD = hydroxypropyl-β-cyclodextrin; GalβChol = d-galactose β cholestanol; GChol = GlcNAcβChol; GGChol = GlcNAcβ1,3 GalβChol; GlcNAcβ1,3 = N-acetyl-d-glucosamine β1,3; GluR1 = glutamate receptor 1; GluR4 = glutamate receptor 4; HO342 = Hoechst 33342; MDC = monodansylcadaverine; mTOR = mammalian target of rapamycin; PARP = poly (adenosine diphosphate-ribose) polymerase; PI3K = phosphatidylinositol 3-kinase; Z-VAD-FMK = benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone.
Article Information

Contributor Notes

Address correspondence to: Ahmad Faried, M.D., Ph.D., Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran–Dr. Hasan Sadikin Hospital, Jl. Pasteur No. 38, Bandung, West Java 40161, Indonesia. email: faried.fkup@gmail.com.Please include this information when citing this paper: published online March 28, 2014; DOI: 10.3171/2014.1.JNS131534.
Headings
References
  • 1

    Biederbick AKern HFElsässer HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 66:3141995

    • Search Google Scholar
    • Export Citation
  • 2

    Bower MNewlands ESBleehen NMBrada MBegent RJCalvert H: Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40:4844881997

    • Search Google Scholar
    • Export Citation
  • 3

    Bursch WEllinger AGerner CFröhwein USchulte-Hermann R: Programmed cell death (PCD). Apoptosis, autophagic PCD, or others?. Ann N Y Acad Sci 926:1122000

    • Search Google Scholar
    • Export Citation
  • 4

    Chamberlain MCKormanik PA: Practical guidelines for the treatment of malignant gliomas. West J Med 168:1141201998

  • 5

    Chipuk JEKuwana TBouchier-Hayes LDroin NMNewmeyer DDSchuler MM: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:101010142004

    • Search Google Scholar
    • Export Citation
  • 6

    Edinger ALThompson CB: Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16:6636692004

  • 7

    Fahy BNSchlieman MGVirudachalam SBold RJ: Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg 198:5915992004

    • Search Google Scholar
    • Export Citation
  • 8

    Faried AFaried LSNakagawa TYamauchi TKitani MSasabe H: Chemically synthesized sugar-cholestanols possess a preferential anticancer activity involving promising therapeutic potential against human esophageal cancer. Cancer Sci 98:135813672007

    • Search Google Scholar
    • Export Citation
  • 9

    Faried AFaried LSUsman NKato HKuwano H: Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol 14:359336012007

    • Search Google Scholar
    • Export Citation
  • 10

    Faried LSFaried AKanuma TNakazato TTamura TKuwano H: Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Eur J Cancer 42:9349472006

    • Search Google Scholar
    • Export Citation
  • 11

    Fraser MLeung BJahani-Asl AYan XThompson WETsang BK: Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 1:662003

    • Search Google Scholar
    • Export Citation
  • 12

    Fritz GJust IKaina B: Rho GTPases are over-expressed in human tumors. Int J Cancer 81:6826871999

  • 13

    Goto JSuzaki KNambara T: Synthesis of conjugated cholesterol and cholestanols. Chem Pharm Bull (Tokyo) 27:192619311979

  • 14

    Hashimoto STsuboi KAsao TKuwano HNishimura TNakagawa T: Anti-tumor effect of chemically synthesized novel glycoconjugates. Glycoconj J 22:3112005

    • Search Google Scholar
    • Export Citation
  • 15

    Hahismoto SYazawa SAsao TFaried ANishimura TTsuboi K: Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells. Glycoconj J 25:5315442008

    • Search Google Scholar
    • Export Citation
  • 16

    Hoelzinger DBMariani LWeis JWoyke TBerens TJMcDonough WS: Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7162005

    • Search Google Scholar
    • Export Citation
  • 17

    Hoorens AVan de Casteele MKlöppel GPipeleers D: Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:156815741996

    • Search Google Scholar
    • Export Citation
  • 18

    Horiuchi AImai TWang COhira SFeng YNikaido T: Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83:8618702003

    • Search Google Scholar
    • Export Citation
  • 19

    Ishiuchi SNakazato YIino MOzawa STamura MOhye C: In vitro neuronal and glial production and differentiation of human central neurocytoma cells. J Neurosci Res 51:5265351998

    • Search Google Scholar
    • Export Citation
  • 20

    Ishiuchi STsuzuki KYoshida YYamada NHagimura NOkado H: Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:9719782002

    • Search Google Scholar
    • Export Citation
  • 21

    Ishiuchi SYoshida YSugawara KAihara MOhtani TWatanabe T: Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:798780012007

    • Search Google Scholar
    • Export Citation
  • 22

    Jin S: p53, autophagy and tumor suppression. Autophagy 1:1711732005

  • 23

    Kamai TTsujii TArai KTakagi KAsami HIto Y: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9:263226412003

    • Search Google Scholar
    • Export Citation
  • 24

    Kanzawa TGermano IMKomata TIto HKondo YKondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11:4484572004

    • Search Google Scholar
    • Export Citation
  • 25

    Kondo YKanzawa TSawaya RKondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:7267342005

    • Search Google Scholar
    • Export Citation
  • 26

    Lefranc FBrotchi JKiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:241124222005

    • Search Google Scholar
    • Export Citation
  • 27

    Liang XHJackson SSeaman MBrown KKempkes BHibshoosh H: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:6726761999

    • Search Google Scholar
    • Export Citation
  • 28

    Manning TJ JrParker JCSontheimer H: Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil Cytoskeleton 45:1851992000

    • Search Google Scholar
    • Export Citation
  • 29

    McCormick F: Cancer: survival pathways meet their end. Nature 428:2672692004

  • 30

    Mihara MErster SZaika APetrenko OChittenden TPancoska P: p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:5775902003

    • Search Google Scholar
    • Export Citation
  • 31

    Miyashita TKrajewski SKrajewska MWang HGLin HKLiebermann DA: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:179918051994

    • Search Google Scholar
    • Export Citation
  • 32

    Munafó DBColombo MI: A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114:361936292001

    • Search Google Scholar
    • Export Citation
  • 33

    Nelson DAWhite E: Exploiting different ways to die. Genes Dev 18:122312262004

  • 34

    Newton HB: Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Curr Opin Investig Drugs 8:100910212007

    • Search Google Scholar
    • Export Citation
  • 35

    Nguyen DMChen GAReddy RTsai WSchrump WDCole G Jr: Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg 127:3653752004

    • Search Google Scholar
    • Export Citation
  • 36

    Nichols WWMurphy DGCristofalo VJToji LHGreene AEDwight SA: Characterization of a new human diploid cell strain, IMR-90. Science 196:60631977

    • Search Google Scholar
    • Export Citation
  • 37

    Oda KArakawa HTanaka TMatsuda KTanikawa CMori T: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:8498622000

    • Search Google Scholar
    • Export Citation
  • 38

    Ogier-Denis ECodogno P: Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 1603:1131282003

  • 39

    Osaki MOshimura MIto H: PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9:6676762004

  • 40

    Paglin SHollister TDelohery THackett NMcMahill MSphicas E: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61:4394442001

    • Search Google Scholar
    • Export Citation
  • 41

    Petiot AOgier-Denis EBlommaart EFMeijer AJCodogno P: Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 275:9929982000

    • Search Google Scholar
    • Export Citation
  • 42

    Sasaki ATamura MHasegawa MIshiuchi SHirato JNakazato Y: Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry. J Neuropathol Exp Neurol 57:6536631998

    • Search Google Scholar
    • Export Citation
  • 43

    Selvakumaran MLin HKMiyashita TWang HGKrajewski SReed JC: Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9:179117981994

    • Search Google Scholar
    • Export Citation
  • 44

    Shintani TKlionsky DJ: Autophagy in health and disease: a double-edged sword. Science 306:9909952004

  • 45

    Stupp RMason WPvan den Bent MJWeller MFisher BTaphoorn MJ: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:9879962005

    • Search Google Scholar
    • Export Citation
  • 46

    Wang CWKlionsky DJ: The molecular mechanism of autophagy. Mol Med 9:65762003

  • 47

    Yan BChour HHPeh BKLim CSalto-Tellez M: RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci Lett 407:1241262006

    • Search Google Scholar
    • Export Citation
  • 48

    Yung WKPrados MDYaya-Tur RRosenfeld SSBrada MFriedman HS: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17:276227711999

    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 13 13 13
Full Text Views 339 185 6
PDF Downloads 201 69 0
EPUB Downloads 0 0 0
PubMed
Google Scholar